Last reviewed · How we verify

NCT04992845: FUTURE

Fusionless Treatment of Idiopathic Scoliosis With the SCOLI-TETHER System During The Growth Period

Terminated NA Last updated 15 March 2024
What this trial tests

NA trial testing Anterior Vertebral Body Tethering in Adolescent Idiopathic Scoliosis in 44 participants. Terminated before completion.

Timeline
15 April 2019
Primary endpoint
1 September 2023
1 September 2023

Quick facts

Lead sponsorSpino Modulation Inc.
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment44
Start date15 April 2019
Primary completion1 September 2023
Estimated completion1 September 2023
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Spino Modulation Inc.

Who can join

Adults 9 to 18, any sex, with Adolescent Idiopathic Scoliosis or Juvenile Idiopathic Scoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the study is to establish the safety and benefit of treatment of juvenile and adolescent idiopathic scoliosis (AIS) with the SCOLI-TETHER (MIScoli) System.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Anterior Vertebral Body Tethering

Trials testing the same drug.

Other recruiting trials for Adolescent Idiopathic Scoliosis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04992845.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing